The Oncology Institute, Inc.
Health
Performance
8.0
Risk
Sell
Buy
Curious about the Scores? Learn more.

The Oncology Institute, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

23.07.2026
Slowing down. Might be a breather – or a shift.
16.07.2026
Almost falling apart. Core metrics remain shaky and unstable.
16.06.2026
Trouble brewing. Volatility and pressure rising.
TOI
The Oncology Institute, Inc.
4.94
+3.56%
8.0
Sell
Buy
The Oncology Institute, Inc.

The Oncology Institute, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does The Oncology Institute, Inc. do? Business model and key facts

Get the full picture of The Oncology Institute, Inc.: what it builds, where it operates, and how it makes money.

The Oncology Institute, Inc. Profile

Sector: Healthcare

Industry: Medical - Care Facilities

Employees (FY): 641

The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Its comprehensive offerings include direct physician care, integrated on-site infusion and medication dispensing facilities, and advanced clinical trial management. The institute also provides radiation therapy, specialized outpatient programs for stem cell transplants and transfusions, and robust patient support services. Furthermore, TOI is actively involved in operating palliative care initiatives and overseeing clinical trials. These services are specifically designed to meet the needs of adult and senior cancer patients. The company maintains a significant operational footprint with 67 clinic locations. The Oncology Institute was established in 2007 and is headquartered in Cerritos, California.

shop
Company facts
Daniel Virnich
CEO
641
Employees worldwide
shop
Performance
31.77%
Last 12 months
-52.01%
Last 5 years
shop
Growth
$502.73M
Revenue year
$-60,606,000
Net income
shop
Valuation
$497.91M
Market Cap
-6.59
Price/Earnings Ratio

Stocks related to The Oncology Institute, Inc.

Selected based on industry alignment and relative market positioning.

EHAB
Enhabit, Inc.
13.80
+0.07%
6.1
Sell
Buy
Enhabit, Inc.
SNDA
Sonida Senior Living, Inc.
40.54
-0.53%
4.4
Sell
Buy
Sonida Senior Living, Inc.
TALK
Talkspace, Inc.
5.23
+0.10%
2.6
Sell
Buy
Talkspace, Inc.
VMD
Viemed Healthcare, Inc.
11.72
+0.56%
4.8
Sell
Buy
Viemed Healthcare, Inc.
CYH
Community Health Systems, Inc.
2.73
+0.74%
7.8
Sell
Buy
Community Health Systems, Inc.

Events and news impacting The Oncology Institute, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

The Oncology Institute, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.